The FDA labeled 22,769 Baxter drug infusion devices as a Class I recall after receiving reports of false upstream occlusion alarms, which can delay therapy.
Read the full post on Becker's Hospital Review - Healthcare News
The FDA labeled 22,769 Baxter drug infusion devices as a Class I recall after receiving reports of false upstream occlusion alarms, which can delay therapy.
Read the full post on Becker's Hospital Review - Healthcare News